A study of rivastigmine liposomes for delivery into the brain through intranasal route

Acta Pharmaceutica

Volumn 58, Issue 3, 2008, Pages 287-297

  Arumugam, Karthik ^a   Subramanian, Ganesa Sundararajan ^a   Mallayasamy, Surulivel Rajan ^a   Averineni, Ranjith Kumar ^a   Reddy, Meka Sreenivasa ^a   Udupa, Nayanabhirama ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Brain drug delivery; Intranasal administration; Liposomes; Pharmacokinetics; Rivastigmine

Indexed keywords

CHOLESTEROL; LIPOSOME; PHOSPHATIDYLCHOLINE; RIVASTIGMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG FORMULATION; DRUG HALF LIFE; DRUG STABILITY; LIPOSOMAL DELIVERY; MALE; MAXIMUM PLASMA CONCENTRATION; MICROENCAPSULATION; NONHUMAN; PARTICLE SIZE; RAT; SCANNING ELECTRON MICROSCOPY; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 53549135761     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-008-0014-3     Document Type: Article

References (20)

1. Y. W. Chien and Y. Chang, Historical Developments of Transnasal Systemic Medications, in Transnasal Systemic Medications: Fundamentals, Developmental Concepts and Biomedical Assessments (Ed. Y. W. Chien), Elsevier, Amsterdam 1985, pp. 1-100.
2. A. A. Hussain, Intranasal drug delivery, Adv. Drug Deliv. Rev. 29 (1998) 39-4; DOI: 10.1016/S0169-409X (97)00060-4.
3. N. S. Barakat, S. A. Omar and A. A. E. Ahmed, Carbamazepine uptake into rat brain following intra-olfactory transport, J. Pharm. Pharmacol. 58 (2005) 63-72; DOI: 10.1211/jpp.58.1.0008.
4. M. Dahlin, U. Bergman, B. Jansson, E. Bjork and E. Brittebo, Transfer of dopamine in the olfactory pathway following nasal administration in mice, Pharm. Res. 17 (2000) 737-742; DOI: 10.1023/A:1007542618378.
5. J. Henriksson and H. Tjalve, Uptake of inorganic mercury in the olfactory bulbs via olfactory pathways in rats, Environ. Res. 77 (1998) 130-140; DOI:10.1006/enrs.1997.3817.
6. K. J. Chou and M. D. Donovan, Lidocaine distribution into the CNS following nasal and arterial delivery: a comparision of local sampling and microdialysis techniques, Int. J. Pharm. 171 (1998) 53-61; DOI: 10.1016/S0378-5173(98)00170-7s.
7. C. Eriksson, U. Bergman, A. Franzen, M. Sjoblom and E. B. Brittebo, Transfer of some carboxylic acids in the olfactory system following intranasal administration, J. Drug Target. 7 (1997) 131-142.
8. W. H. Prey, J. Liu, X. Chen, R. G. Thorne, J. R. Fawcett, T. A. Ala and Y. E. Rahman, Delivery of 125I-NGF to the brain via the olfactory route, Drug Deliv. 4 (1997) 87-92; DOI: 10.3109/10717549709051878.
9. R. G. Thorne, C. R. Emory, T. A. Ala and W. H. Frey, Quantitative analysis of the olfactory pathway for drug delivery to the brain, Brain Res. 692 (1995) 278-282; DOI: 10.1016/0006-8993(95)00637-6.
10. L. Illum, Transport of drugs from the nasal cavity to the central nervous system, Eur. J. Pharm. Sci. 11 (2000)1-18; DOI: 10.1016/S0928-0987(00)00087-7.
11. J. L. Cummings and G. Cole, Alzheimer disease, JAMA 287 (2002) 2335-2338; DOI: 10.1001/jama.287.18.2335.
12. R. J. Polinsky, Clinical pharmacology of rivastigmine: A new generation acetyl choline esterase inhibitor for the treatment of Alzheimer's disease, Clin. Ther. 20 (1998) 634-637; DOI: 10.1016/S0149-2918(98)80127-6.
13. K. Muramatsu, Y. Maitani, K. Takayama and T. Nagai, The relationship between the rigidity of the liposomal membrane and the absorption of insulin after nasal administration of liposomes modified with an enhancer containing insulin in rabbits, Drug Dev. Ind. Pharm. 25 (1999) 1099-1105; DOI: 10.1081/DDC-100102275.
14. S. L. Law, K. J. Huang and H. Y. Chou, Preparation of desmopressin-containing liposomes for intranasal delivery, J. Control. Rel. 70 (2001) 375-382; DOI: 10.1016/S0168-3659(00)00369-2.
15. K. Iwanaga, S. Matsumoto, K. Morimoto, M. Kakemi, S. Yamashita and T. Kimura, Usefulness of liposomes as an intranasal dosage formulation for topical drug application, Biol. Pharm. Bull. 23 (2000) 323-326.
16. K. A. Edwards, and A. J. Baeumner, Analysis of liposomes, Talanta 68 (2006) 1432-1441; DOI: 10.1016/j.talanta.2005.08.031.
17. E. Maria, B. Estradaa, M. Foldvari, M. Snider and K. Harding, Intranasal immunization with liposome-formulated Yersinia pestis vaccine enhances mucosal immune responses, Vaccine 18 (2000) 2203-2211; DOI: 10.1016/S0264-410X(00)00019-0.
18. United States Pharmacopoeia 23, National Formulary 18, USP Convention, Rockville, 2005.
19. B. J. Balin, R. D. Broadwell, M. Salcman and M. El-Kalliny, Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey, J. Comp. Neurol. 251 (1986) 260-280; DOI: 10.1002/cne.902510209.
20. M. P. van den Berg, J. Coos Verhoef, S. G. Romeijn and F. W. H. M. Merkus, Uptake of estradiol or progesterone into the CSF following intranasal and intravenous delivery in rats, Eur. J. Pharm. Sci. 58 (2004) 131-135; DOI: 10.1016/j.ejpb.2004.02.010.